Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neuromyelitis optica spectrum disorder in Latin America: a global data share initiative.

Multiple sclerosis and related disorders·2025

Same author

Ecology and risks of the global plastisphere as a newly expanding microbial habitat.

Innovation (Cambridge (Mass.))·2023

Same author

G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K/Akt Activation in Bladder Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2023

Same author

Biomineralization To Prevent Microbially Induced Corrosion on Concrete for Sustainable Marine Infrastructure.

Environmental science & technology·2023

Same author

Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinoma.

BJU international·2023

Same author

Chromosome genome assembly and whole genome sequencing of 110 individuals of Conogethes punctiferalis (Guenée).

Scientific data·2023

Search research articles

Related Experiment Video

Updated: May 28, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

Temporal regulation of rapamycin on memory CTL programming by IL-12.

Xiangdong Li¹, Karla Garcia, Zhifeng Sun

¹Department of Animal and Avian Sciences, University of Maryland, College Park, Maryland, United States of America.

|October 4, 2011

Summary

Rapamycin regulates memory cytotoxic T lymphocyte (CTL) programming by IL-12 similarly across concentrations. Enhanced memory CTLs showed improved proliferation and protection, with rapamycin

More Related Videos

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Related Experiment Videos

Last Updated: May 28, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14⁺ Monocytes

Published on: April 11, 2025

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Area of Science:

Immunology
Cell Biology
Pharmacology

Background:

Mammalian target of rapamycin (mTOR) is crucial for cell growth and T lymphocyte differentiation.
Recent studies highlight mTOR's role in memory cytotoxic T lymphocyte (CTL) programming during infections.

Purpose of the Study:

To investigate the effect of rapamycin on memory CTL programming, function, and proliferation.
To determine the temporal windows for rapamycin's regulatory effects on CTL phenotype and size.

Main Methods:

Treatment of CTLs with varying concentrations of rapamycin.
Assessment of memory CTL function and protection against Listeria Monocytogenes.
Analysis of CTL proliferation post-transfer into recipients.
Evaluation of CD62L expression and cell size changes over time.

Main Results:

Rapamycin regulated IL-12-driven memory CTL programming consistently across a broad concentration range.
Rapamycin-enhanced memory CTLs were functional, offering comparable protection against Listeria Monocytogenes.
Rapamycin treatment led to significantly enhanced proliferation of CTLs after adoptive transfer.
Rapamycin's effect on CD62L expression was primarily observed within the initial 24 hours of in vitro stimulation.
The effective window for rapamycin's impact on memory CTL size was between 24 and 72 hours of stimulation.

Conclusions:

Rapamycin modulates IL-12-driven CTL programming effectively across diverse concentrations.
Rapamycin influences memory CTL phenotype and size through distinct temporal windows.
Rapamycin enhances memory CTL function, proliferation, and protective capacity.